Biotech Sees Massive Buying Pressure Following Phase 2 Preliminary Data

US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Biotech Sees Massive Buying Pressure Following Phase 2 Preliminary Data

A California-based biotech company is finding early success on Tuesday after the company announced positive preliminary data of Vebreltinib in patients with non-CNS met fusion...

To read the full story on AllPennyStocks.com, click here.

Apollomics (NASDAQ:APLMW)
Gráfica de Acción Histórica
De Mar 2025 a Abr 2025

Haga Click aquí para más Gráficas Apollomics.

Apollomics (NASDAQ:APLMW)
Gráfica de Acción Histórica
De Abr 2024 a Abr 2025

Haga Click aquí para más Gráficas Apollomics.

Noticias sobre Apollomics Inc APLMW

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jueves 3 de Abril 2025 (2 días hace) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jueves 3 de Abril 2025 (2 días hace) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lunes 31 de Marzo 2025 (6 días hace) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Viernes 10 de Enero 2025 (3 meses hace) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Viernes 20 de Diciembre 2024 (4 meses hace) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Martes 10 de Diciembre 2024 (4 meses hace) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jueves 14 de Noviembre 2024 (5 meses hace) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Viernes 1 de Noviembre 2024 (5 meses hace) • Edgar (US Regulatory)

Biotech Sees Massive Buying Pressure Following Phase 2 Preliminary Data
Martes 13 de Agosto 2024 (8 meses hace) • AllPennyStocks.com

Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Martes 4 de Junio 2024 (10 meses hace) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jueves 30 de Mayo 2024 (10 meses hace) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Miércoles 29 de Mayo 2024 (10 meses hace) • Edgar (US Regulatory)

Más de Apollomics Inc Artículos de Noticias

Deutsche Telekom (QX)

American Express

Energy Select Sector SPDR

Verizon Communications

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones